These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 27984730)

  • 1. Naturally Occurring Off-Switches for CRISPR-Cas9.
    Pawluk A; Amrani N; Zhang Y; Garcia B; Hidalgo-Reyes Y; Lee J; Edraki A; Shah M; Sontheimer EJ; Maxwell KL; Davidson AR
    Cell; 2016 Dec; 167(7):1829-1838.e9. PubMed ID: 27984730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
    Rousseau BA; Hou Z; Gramelspacher MJ; Zhang Y
    Mol Cell; 2018 Mar; 69(5):906-914.e4. PubMed ID: 29456189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.
    Zhu Y; Gao A; Zhan Q; Wang Y; Feng H; Liu S; Gao G; Serganov A; Gao P
    Mol Cell; 2019 Apr; 74(2):296-309.e7. PubMed ID: 30850331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
    Hoffmann MD; Mathony J; Upmeier Zu Belzen J; Harteveld Z; Aschenbrenner S; Stengl C; Grimm D; Correia BE; Eils R; Niopek D
    Nucleic Acids Res; 2021 Mar; 49(5):e29. PubMed ID: 33330940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
    Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
    Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inhibition of CRISPR-Cas9 by anti-CRISPR protein AcrIIC1.
    Zhu Y; Yin S; Li Z
    Biochem Biophys Res Commun; 2023 Apr; 654():34-39. PubMed ID: 36878037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
    Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
    FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2.
    Thavalingam A; Cheng Z; Garcia B; Huang X; Shah M; Sun W; Wang M; Harrington L; Hwang S; Hidalgo-Reyes Y; Sontheimer EJ; Doudna J; Davidson AR; Moraes TF; Wang Y; Maxwell KL
    Nat Commun; 2019 Jun; 10(1):2806. PubMed ID: 31243272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.
    Rauch BJ; Silvis MR; Hultquist JF; Waters CS; McGregor MJ; Krogan NJ; Bondy-Denomy J
    Cell; 2017 Jan; 168(1-2):150-158.e10. PubMed ID: 28041849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the anti-CRISPR, AcrIIC4.
    Kim GE; Lee SY; Park HH
    Protein Sci; 2021 Dec; 30(12):2474-2481. PubMed ID: 34676610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4.
    Li X; Liao F; Gao J; Song G; Zhang C; Ji N; Wang X; Wen J; He J; Wei Y; Zhang H; Li Z; Yu G; Yin H
    Nucleic Acids Res; 2023 Sep; 51(17):9442-9451. PubMed ID: 37587688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing.
    Bolukbasi MF; Liu P; Luk K; Kwok SF; Gupta A; Amrani N; Sontheimer EJ; Zhu LJ; Wolfe SA
    Nat Commun; 2018 Nov; 9(1):4856. PubMed ID: 30451839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
    Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
    Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
    Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
    Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Investigation of Self-Assembly and Target Binding of Anti-CRISPR AcrIIC2.
    Kim Y; Lee SJ; Park C; Koo J; Bae E; Lee BJ; Suh JY
    CRISPR J; 2021 Jun; 4(3):448-458. PubMed ID: 34042500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
    Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
    Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.